There has been no rush to buy or sell CVS, based on this quarterly. Perhaps the buyers' hesitation is based on the mere $273,000 that CVS has in the bank. Let's see what rdnoic makes of it all.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor